New Schizophrenia Treatments Are Coming: Don't Panic
(MedPage Today) -- At the recent Psych Congress 2023, a session titled "State of the Science: Focus on Schizophrenia" was presented by Peter J. Weiden, MD, a clinical professor of psychiatry at the Renaissance School of Medicine at Stony Brook... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 26, 2023 Category: Psychiatry Source Type: news
A cognitive-behavioral suicide prevention treatment for adults with schizophrenia spectrum disorders in community mental health: preliminary findings of an open pilot study - Bornheimer LA, Verdugo JL, Krasnick J, Jeffers N, Storey F, King CA, Taylor SF, Florence T, Himle JA.
Suicide is a leading cause of death among schizophrenia spectrum disorder populations. This open pilot study examined a modified cognitive-behavioral suicide prevention treatment for clients in community mental health. Providers (n=5) were trained to deliv... (Source: SafetyLit)
Source: SafetyLit - September 25, 2023 Category: International Medicine & Public Health Tags: Program and Other Evaluations, Effectiveness Studies Source Type: news
Adverse Childhood Experiences Common in Schizophrenia
WEDNESDAY, Sept. 20, 2023 -- Patients with schizophrenia often have adverse childhood experiences (ACEs), according to a study published online Aug. 28 in Frontiers in Psychiatry.
Lei Zhang, Ph.D., from Tongji University in Shanghai, and colleagues... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 20, 2023 Category: Pharmaceuticals Source Type: news
Schizophrenia Sexual Dysfunction; Nuplazid Box Warning Tweak; Psych Practice Fraud?
(MedPage Today) -- Over half of people with schizophrenia experienced sexual dysfunction -- 55.7% of men and 60% of women -- according to a meta-analysis of more than 21,000 study participants. (JAMA Psychiatry)
People who used both tobacco... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 20, 2023 Category: Psychiatry Source Type: news
Drug Trials Snapshot: LYBALVI
To treat schizophrenia and certain aspects of bipolar I disorder (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 19, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Risk of all-cause and suicide death in patients with schizophrenia: an entire-population longitudinal study in Taiwan - Cheng CM, Chang WH, Tsai SJ, Li CT, Tsai CF, Bai YM, Lin WC, Su TP, Chen TJ, Chen MH.
BACKGROUND: Schizophrenia increases mortality from all causes and specific causes. Comprehensive research on modifiable risk factors for early mortality from multiple sources is needed. METHODS: Taiwan's National Health Insurance Research Database,... (Source: SafetyLit)
Source: SafetyLit - September 19, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Cannabis Use and Relapse in First Episode Schizophrenia Cannabis Use and Relapse in First Episode Schizophrenia
This study investigates the association between cannabis use and relapse following a first-episode of psychosis. Can patients in remission after their first episode safely use cannabis?Schizophrenia Bulletin (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 19, 2023 Category: Consumer Health News Tags: Psychiatry Journal Article Source Type: news
Matricide and schizophrenia- psychopathological, psychodynamic, and forensic aspects: a case report - Valen ça AM, de Almeida LR, de Oliveira GC, França MF, da Silva AG, Telles LB, Nardi AE.
Matricide is the murder of a mother by her son or daughter, a form of homicide rarely seen in psychiatric practice. A narrative review was conducted on the relationship between matricide and schizophrenia, followed by a case report in Brazil of a schizophr... (Source: SafetyLit)
Source: SafetyLit - September 19, 2023 Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news
Differentiating between sexual offending and violent non-sexual offending in men with schizophrenia spectrum disorders using machine learning - Lau S, Habermeyer E, Hill A, G ünther MP, Machetanz LA, Kirchebner J, Huber D.
Forensic psychiatric populations commonly contain a subset of persons with schizophrenia spectrum disorders (SSD) who have committed sex offenses. A comprehensive delineation of the features that distinguish persons with SSD who have committed sex offenses... (Source: SafetyLit)
Source: SafetyLit - September 16, 2023 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news
Rates of Sexual Dysfunction High in Patients With Schizophrenia
FRIDAY, Sept. 15, 2023 -- There is a high prevalence of sexual dysfunction among individuals with schizophrenia, according to a review published online Sept. 13 in JAMA Psychiatry.
Th éo Korchia, M.D., from Aix-Marseille University in France, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 15, 2023 Category: Pharmaceuticals Source Type: news
Sexual Dysfunction Common in Schizophrenia Sexual Dysfunction Common in Schizophrenia
More than 55% of men and 60% of women with schizophrenia suffer sexual dysfunction, with comorbid depression possibly playing a role.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - September 13, 2023 Category: Psychiatry Tags: Psychiatry News Source Type: news
Santa Barbara World Class Psychiatry: A New Comprehensive Behavioral Health Clinic, Founded by Dr. Adham Malaty, Opens its Doors
Dr. Adham Malaty launches Santa Barbara World Class Psychiatry where his practice will offer comprehensive care that addresses a plethora of mental health concerns, spanning from anxiety disorders, depression and bipolar disorder to complex neuropsychiatric conditions, Schizophrenia, PTSD... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 13, 2023 Category: Pharmaceuticals Source Type: news
Safety Profile Sways Physicians on Use of LAIs for Schizophrenia
(MedPage Today) -- NASHVILLE, Tenn. -- Psychiatric care providers most often ranked the side effect profile of long-acting injectables (LAIs) for schizophrenia as the top consideration when prescribing the antipsychotics to patients, a survey... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 12, 2023 Category: Psychiatry Source Type: news
Long-Acting Schizophrenia Tx Shows Long-Term Safety With Limited Relapses
(MedPage Today) -- NASHVILLE, Tenn. -- Every-6-month dosing of the long-acting injectable paliperidone palmitate (Invega Hafyera) for schizophrenia was effective and safe up to 3 years, researchers reported here.
In an intention-to-treat analysis... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 11, 2023 Category: Psychiatry Source Type: news
Linking childhood trauma and dissociation to psychotic symptoms in major depressive disorder, bipolar disorders, and schizophrenia: a transdiagnostic examination using patient and clinician ratings - Chiu CD, Li DJ, Hsieh YC, Chou LS, Au JS, Chen YL, Lin CH.
OBJECTIVE: Symptomatic overlap between dissociation and psychosis is well documented; however, the pathogenesis of these two phenomena might be distinct. Few studies have analyzed the relation of dissociative and psychotic symptoms transdiagnostically. The... (Source: SafetyLit)
Source: SafetyLit - September 11, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
